Connect with us

Press Release

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

Published

2 years ago

on

–News Direct–

By Austin DeNoce, Benzinga

Autonomix Medical (NASDAQ: AMIX) is a medical device company dedicated to transforming the diagnosis and treatment of diseases or disorders related to the nervous system. At the core of Autonomix's innovative approach is a first-in-class technology platform featuring a catheter-based microchip sensing array. This technology boasts an unprecedented ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than existing technologies. This breakthrough has paved the way for transvascular diagnosis and treatment of nervous system diseases virtually anywhere in the body, offering a new horizon of medical possibilities and market opportunities.

Clinical Studies In Pancreatic Cancer Pain

Autonomix has initiated its first clinical study targeting pancreatic cancer pain, marking a significant milestone in its ongoing medical innovation. Pancreatic cancer represents a considerable unmet medical need, particularly concerning pain management. Effective solutions in this area are critically needed, as current relief options for pancreatic diseases are limited to drugs like opioids. In light of that, the initiation of these clinical studies represents a crucial step toward addressing this substantial healthcare challenge for suffering patients.

Market Opportunities

In addition to addressing the pain relief needs of patients, Autonomixs technology presents significant market opportunities across various medical fields. By accurately targeting the nervous system, Autonomix aims to address unmet needs and improve treatments for a wide range of conditions including but not limited to:

  • Pancreatic Cancer Pain: The successful application of Autonomix's technology in pancreatic cancer pain management would not only help pancreatic cancer patients find relief from pain but also unlocks significant market potential. Pancreatic cancer pain management is part of a $2.2 billion market for pancreatic cancer treatment.

  • Chronic Pain: This market presents a significant opportunity estimated at $75 billion. Conditions such as lower back pain, pelvic pain, urinary tract pain, digestive disorders and other tumor-related pain are prevalent and often inadequately managed with current therapies, particularly opioids. Autonomix's technology offers the potential to significantly reduce or eliminate the dependence on opioids, providing a safer and more effective solution for chronic pain management.

  • Cardiovascular Diseases: With a market opportunity estimated at $23 billion, Autonomix's technology could revolutionize the treatment of conditions like hypertension and cardiovascular disease. By targeting the nervous system's role in these diseases, more precise and effective treatments could be developed.

  • Pulmonary Diseases: Chronic obstructive pulmonary disease (COPD) is another area where Autonomix's technology could have a substantial impact. The market for COPD treatments is estimated to be around $18 billion with considerable growth ahead, driven by the need for more effective and less side-effect-prone therapies. Autonomix's approach could provide a new paradigm in managing this debilitating condition.

Meeting Unmet Needs with Innovative Solutions

Current drug therapies for many of these conditions often come with significant side effects and do not adequately address the underlying issues. Autonomix's technology offers a promising alternative by providing targeted, nerve-based treatments that could improve patient outcomes and quality of life. This innovative approach aligns with Autonomix's mission to dramatically enhance the lives of millions by enabling precise and effective nerve-targeted treatments. In doing so, Autonomix can both detect and ablate malfunctioning nerves in one simple procedure, effectively opening new treatment options in the field of electrophysiology.

The Full Opportunity

Autonomix Medical sits at the forefront of a potential revolution in medical treatment for diseases driven by the nervous system. The companys advanced technology platform not only offers hope for better management of pancreatic cancer pain, but also opens the door to addressing numerous other conditions with significant unmet need. By providing physicians with powerful new tools for diagnosis and treatment, Autonomix is poised to make a profound impact on the future of healthcare.

Featured photo by Irwan on Unsplash.

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

Some of the statements in this release are forward-looking statements, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the timing of the completion of patient enrollment in the trial and the Companys ability to successfully meet the milestones set forth in this press release on a timely basis, if at all. Such forward-looking statements can be identified by the use of words such as should, may, intends, anticipates, believes, estimates, projects, forecasts, expects, plans, and proposes.Although Autonomix Medical, Inc. (or Autonomix) believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading Risk Factors and elsewhere in the offering circular filed with the U.S. Securities and Exchange Commission (SEC) on January 26, 2024. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.

Contact Details

JTC Team, LLC

autonomix@jtcir.com

Company Website

https://autonomix.com/

View source version on newsdirect.com: https://newsdirect.com/news/this-one-company-is-working-on-a-breakthrough-approach-to-revolutionize-pain-management-840932661

Autonomix Medical, Inc.

comtex tracking

COMTEX_453436019/2655/2024-06-06T09:04:53

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

Sihoo Doro C300 Pro V2 Is Officially Available: The Next Evolution in Full-Body Adaptive Ergonomics

Published

2 hours ago

on

April 20, 2026

By

Featuring the revolutionary DynaCore System, Sihoo’s newest flagship chair eliminates support loss during movement and delivers truly adaptive, personalized comfort.

Shenzhen, China, 20th Apr 2026 – Sihoo, a global leader in ergonomic furniture with 15 years of design and engineering excellence, today announced the official global availability of the highly anticipated Doro C300 Pro V2. Engineered to redefine all-day comfort, this new flagship model is the market’s first ergonomic chair to deliver true, intuitive, full-body adaptive support.

The End of Support Loss During Movement

Building on the global success of the original Doro C300, the Pro V2 sets a new standard for dynamic comfort. At its core is Sihoo’s proprietary DynaCore Full-Body Support System.

Unlike traditional office chairs that lose support the moment you move—or ergonomic chairs that demand constant readjustment—the Doro C300 Pro V2’s DynaCore system seamlessly synchronizes the backrest, lumbar support, headrest, and armrests. The result is a chair that intuitively responds to your natural movements. Whether you lean forward for focused work, shift side to side, or recline to relax, the chair maintains perfect, continuous balance.

Personalized Comfort from the First Moment

The Doro C300 Pro V2 takes personalization further with the SyncroFlex Backrest. The instant you sit down, the chair automatically maps and follows the natural curvature of your spine. Its intelligent recline path adapts dynamically to your unique body size and movement patterns, delivering a highly tailored experience with zero manual adjustments.

Next-Generation Features

The Doro C300 Pro V2 is packed with upgraded technology designed for today’s professionals, gamers, and creators:

  • Self-Adaptive Dynamic Lumbar Support 2.0 — Offers three levels of targeted adjustability for fatigue-reducing lower-back support that lasts all day.
  • 8D Bionic Armrests — Move in eight directions to provide perfect arm support whether you’re typing, gaming with a controller, or scrolling on a mobile device.
  • Ultra-Wide 3D Headrest — Delivers precise, cradle-like neck support to relieve tension during long periods of focus.
  • Weight-Adaptive Mechanism 2.0 — Automatically calibrates recline tension to your body weight, providing an ultra-smooth recline of up to 135° for a seamless transition between work and rest.

Availability

The Sihoo Doro C300 Pro V2 is now officially available in major global markets, including the United States, Germany, and France.

To purchase or learn more about its groundbreaking features, visit: https://sihoooffice.com/pages/sihoo-c300-pro-v2.

About Sihoo

Founded in 2011, Sihoo is driven by a core mission: to create seating solutions that seamlessly combine comfort, robust support, and cutting-edge ergonomic innovation. With 15 years of dedicated expertise in biomechanics and engineering, Sihoo has become a globally recognized brand trusted by modern businesses, remote workers, and households in more than 100 countries.

Media Contact

Organization: Sihoo

Contact Person: Wendy Xu

Website: https://sihoooffice.com/

Email: Send Email

City: Shenzhen

Country:China

Release id:44170

The post Sihoo Doro C300 Pro V2 Is Officially Available: The Next Evolution in Full-Body Adaptive Ergonomics appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Waypoint Expands to 15 Markets in Third Year of Operations

Published

2 hours ago

on

April 20, 2026

By

Waypoint, a career intelligence platform for senior professionals, now serves subscribers across 15 markets in Europe, the Middle East, Asia-Pacific, and North America.

London, United Kingdom, 20th Apr 2026 — Waypoint, a career intelligence platform for senior professionals, has confirmed that it now serves subscribers across 15 markets in Europe, the Middle East, Asia-Pacific, and North America, marking the platform’s third year of operations.

The milestone reflects continued adoption of the career intelligence category among senior professionals who conduct executive-level career moves through direct approach, referral, and retained search channels rather than through publicly advertised roles.

The platform is available to subscribers globally through way.careers.

About the Platform

Waypoint provides subscribers with a personalised dashboard of target companies mapped to their sector and seniority. The dashboard includes named hiring manager contacts, live company hiring signals, direct-approach toolkits, and CV positioning tailored to each target organisation.

Core platform features include:

  • A target-company dashboard of up to 40 organisations per subscriber, mapped to the subscriber’s sector and seniority
  • Named hiring-manager identification at each target organisation
  • Live hiring signals indicating company growth, leadership changes, and organisational restructuring
  • CV and LinkedIn positioning resources tailored to each target
  • Message tracking to indicate when a target recipient has engaged with outreach
  • Direct-approach templates and guidance materials

Regional Coverage

Waypoint subscribers are based across the United Kingdom, France, Germany, Switzerland, the Netherlands, the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, Singapore, Hong Kong, Australia, the United States, and Canada. The service is delivered digitally and is available to any senior professional in a supported market.

Service Tiers

Waypoint is available in multiple subscription tiers. The core service is priced at USD 739 and includes the target-company dashboard and associated toolkits. Additional tiers extend access to job market data, a dedicated career audit, and live operator support. Full pricing and tier details are available on the Waypoint website.

Operations

Waypoint is incorporated in the United Kingdom, with operational functions based in Dubai, United Arab Emirates.

About Waypoint

Waypoint is a career intelligence platform designed for senior professionals conducting executive-level career moves. The service combines target-company dashboards, hiring-manager identification, direct-approach toolkits, and hiring signal intelligence. Waypoint is incorporated in the United Kingdom and operates across 15 international markets. More information is available at way.careers.

Media Contact

Organization: Waypoint Career Intelligence LLC

Contact Person: Peter Campbell

Website: https://way.careers

Email: Send Email

Address:27 Old Gloucester St, London, United Kingdom, WC1N 3AX

City: London

Country:United Kingdom

Release id:44158

The post Waypoint Expands to 15 Markets in Third Year of Operations appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

A Captivating Tale of Passion and Late-Blooming Love: Dancing With Katie by E.P. Lande

Published

2 hours ago

on

April 20, 2026

By

United Kingdom, 20th Apr 2026 – Blue Crystal Literary Magazine proudly presents Dancing With Katie, a deeply evocative and emotionally layered novel by E. P. Lande, now available worldwide. Blending autobiographical elements with fiction, this compelling work explores the transformative power of dance, desire, and human connection.

At the heart of the novel is Aaron, a divorced and reflective former academic living in Vermont, whose quiet, structured life is disrupted by an unexpected calling—to dance. What begins as a simple pursuit soon becomes an all-consuming passion for the Argentine tango, a dance that awakens not only his body but his emotional world.

Aaron’s journey takes him across cities and continents—from rural Vermont to Montreal, New York, and Buenos Aires—in search of mastery, meaning, and ultimately, connection. Along the way, he encounters teachers, dancers, and a vibrant global tango community that shapes his transformation. Yet, despite his relentless pursuit of technical perfection, what Aaron truly lacks is a consistent partner—until he meets Katie.

Katie, a former ballerina with independence and emotional complexity, enters Aaron’s life initially as a dance student. What begins as a practical arrangement soon evolves into something far more intricate. Their shared hours of practice—set against the rhythm and intimacy of the tango—give rise to a relationship that blurs the boundaries between teacher and student, companionship and longing.

As Katie navigates a succession of romantic relationships, Aaron finds himself caught between restraint and desire, reflection and action. His internal struggle—marked by self-examination, jealousy, and hope—forms the emotional core of the novel. Through dance, conversations, and unspoken tensions, their bond deepens, revealing the complexities of timing, love, and missed opportunities.

In its poignant conclusion, Dancing With Katie delivers a powerful realization: that what we seek in life is often already within reach, obscured only by our own distractions and hesitations. The novel closes on a note of emotional clarity and quiet revelation, as both Aaron and Katie confront the truth of their connection.

Written with elegance, wit, and introspective depth, E. P. Lande’s narrative captures not only the sensuality and discipline of the Argentine tango but also its symbolic resonance as a dance of life—one of balance, timing, and mutual understanding. Both a romance and a meditation on self-discovery, the book appeals to readers who appreciate character-driven storytelling and emotional authenticity.

 

 

About the Author

E.P. Lande, originally from Montreal and now based in South Carolina, brings a rich and varied life experience to his writing. A former academic and Vice-Dean, as well as a restaurateur and widely published short story writer, Lande has crafted a narrative voice that is both reflective and deeply human. Dancing With Katie continues his exploration of psychological and emotional landscapes.

 

Publication Details
Title: Dancing With Katie
Author: E. P. Lande
Publisher: Blue Crystal Literary Magazine
Publication Date: 11 April 2026
ISBN: 978-1-0672783-0-4
Format: Paperback, eBook,Hardback
Price: $15.99 USD

Availability

Dancing With Katie is available now through:

 

Also catalogued in:

Media Contact

Organization: Blue Crystal Literary Magazine

Contact Person: Richard Philips

Website: https://bluecrystallit.uk

Email: Send Email

Address:B000803 Unit 4 Tunstall Trade Park

Address 2: Brownhills Road

City: Stoke on Trent

State: Staffordshire

Country:United Kingdom

Release id:44172

The post A Captivating Tale of Passion and Late-Blooming Love: Dancing With Katie by E.P. Lande appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us